The central struggle was between the publicly funded international Human Genome Project, led by Francis Collins, a distinguished scientist and devout Christian, which pursued a slow-and-steady approach to sequencing until Celera, a private company led by Craig Venter, appeared on the scene and boldly claimed that its revolutionary new technique, whole-genome shot-gun sequencing, could do the job in less than half the time.

ECONOMIST: Medical research